Wu TK, Ou YC, Chen YP, Huang FM, et al. Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway. Anticancer Res 2021;41:3789-3799.
PMID: 34281838